WuXi PharmaTech Co., Ltd. Backed Foundation Medicine Files for IPO
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
August 2, 2013 -- Foundation Medicine, a US company that has developed a comprehensive genomic test for cancer abnormalities, made an initial filing for an $86.3 million IPO. Foundation is one of the companies that has received an equity investment from WuXi PharmaTech’s venture fund. It is the first of WuXi’s investments to file for an IPO. More details....
Stock Symbol: (NYSE: WX)
Help employers find you! Check out all the jobs and post your resume.
by Richard Daverman, PhD
August 2, 2013 -- Foundation Medicine, a US company that has developed a comprehensive genomic test for cancer abnormalities, made an initial filing for an $86.3 million IPO. Foundation is one of the companies that has received an equity investment from WuXi PharmaTech’s venture fund. It is the first of WuXi’s investments to file for an IPO. More details....
Stock Symbol: (NYSE: WX)
Help employers find you! Check out all the jobs and post your resume.